RTW Biotech Opportunities (RTW) Competitors GBX 1.22 +0.01 (+0.83%) As of 11:46 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock RTW vs. WTAN, RAT, FEV, BRW, MYI, BHMU, SNN, WWH, JTC, and FGTShould you be buying RTW Biotech Opportunities stock or one of its competitors? The main competitors of RTW Biotech Opportunities include Witan Investment Trust (WTAN), Rathbones Group (RAT), Fidelity European Trust (FEV), Brewin Dolphin (BRW), Murray International (MYI), BH Macro USD (BHMU), Sanne Group (SNN), Worldwide Healthcare (WWH), JTC (JTC), and Finsbury Growth & Income (FGT). These companies are all part of the "asset management" industry. RTW Biotech Opportunities vs. Witan Investment Trust Rathbones Group Fidelity European Trust Brewin Dolphin Murray International BH Macro USD Sanne Group Worldwide Healthcare JTC Finsbury Growth & Income Witan Investment Trust (LON:WTAN) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Does the media refer more to WTAN or RTW? In the previous week, RTW Biotech Opportunities had 1 more articles in the media than Witan Investment Trust. MarketBeat recorded 1 mentions for RTW Biotech Opportunities and 0 mentions for Witan Investment Trust. Witan Investment Trust's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score. Company Overall Sentiment Witan Investment Trust Neutral RTW Biotech Opportunities Neutral Does the MarketBeat Community prefer WTAN or RTW? Witan Investment Trust received 93 more outperform votes than RTW Biotech Opportunities when rated by MarketBeat users. However, 100.00% of users gave RTW Biotech Opportunities an outperform vote while only 67.63% of users gave Witan Investment Trust an outperform vote. CompanyUnderperformOutperformWitan Investment TrustOutperform Votes9467.63% Underperform Votes4532.37% RTW Biotech OpportunitiesOutperform Votes1100.00% Underperform VotesNo Votes Do insiders & institutionals hold more shares of WTAN or RTW? 8.5% of Witan Investment Trust shares are held by institutional investors. Comparatively, 3.9% of RTW Biotech Opportunities shares are held by institutional investors. 8.2% of Witan Investment Trust shares are held by insiders. Comparatively, 16.2% of RTW Biotech Opportunities shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk and volatility, WTAN or RTW? Witan Investment Trust has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Comparatively, RTW Biotech Opportunities has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. Is WTAN or RTW more profitable? RTW Biotech Opportunities has a net margin of 664.38% compared to Witan Investment Trust's net margin of 89.43%. RTW Biotech Opportunities' return on equity of 25.18% beat Witan Investment Trust's return on equity.Company Net Margins Return on Equity Return on Assets Witan Investment Trust89.43% 13.68% 7.95% RTW Biotech Opportunities 664.38%25.18%-0.47% Which has stronger valuation & earnings, WTAN or RTW? RTW Biotech Opportunities has higher revenue and earnings than Witan Investment Trust. Witan Investment Trust is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWitan Investment Trust£246.38M0.00£220.34M£0.36N/ARTW Biotech Opportunities£2.12B0.19£14.09B£0.422.91 SummaryRTW Biotech Opportunities beats Witan Investment Trust on 8 of the 13 factors compared between the two stocks. Get RTW Biotech Opportunities News Delivered to You Automatically Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RTW vs. The Competition Export to ExcelMetricRTW Biotech OpportunitiesAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£409.82M£1.16B£3.85B£2.59BDividend YieldN/A4.46%4.21%4.97%P/E Ratio2.9121.6512.97133.69Price / Sales0.192,296.061,700.09239,757.82Price / Cash0.3261.2950.3828.12Price / Book0.011.123.404.55Net Income£14.09B£262.20M£1.24B£5.84B7 Day PerformanceN/A1.35%1.14%3.43%1 Month Performance2.95%5.67%10.87%10.59%1 Year Performance-7.58%2.70%12.63%117.06% RTW Biotech Opportunities Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RTWRTW Biotech OpportunitiesN/AGBX 1.22+0.8%N/A-7.7%£409.82M£2.12B2.914,971News CoverageWTANWitan Investment TrustN/AN/AN/AN/A£1.58B£246.38M738.896RATRathbones Group2.9117 of 5 starsGBX 1,520+1.1%N/A-3.0%£1.58B£874.75M24.743,500Analyst ForecastHigh Trading VolumeFEVFidelity European TrustN/AGBX 383.50+2.3%N/A+1.3%£1.58B£221.98M7.60N/ABRWBrewin DolphinN/AN/AN/AN/A£1.56B£415.46M3,029.412,186MYIMurray InternationalN/AGBX 258+1.6%N/A+6.8%£1.54B£198.15M8.58N/ADividend AnnouncementNews CoverageBHMUBH Macro USDN/AGBX 4.07-0.8%N/A+8.6%£1.51B£2.88B34.95N/AHigh Trading VolumeSNNSanne GroupN/AN/AN/AN/A£1.50B£194.16M-204.6720,100WWHWorldwide HealthcareN/AGBX 281.50+3.1%N/A-15.0%£1.50B£245.62M6.55N/ANews CoveragePositive NewsHigh Trading VolumeJTCJTC2.8894 of 5 starsGBX 827+2.5%GBX 1,400+69.3%-1.5%£1.39B£291.42M46.381,603FGTFinsbury Growth & IncomeN/AGBX 895.34+1.1%N/A+9.7%£1.33B£101.41M14.71N/ANews CoveragePositive News Related Companies and Tools Related Companies WTAN Alternatives RAT Alternatives FEV Alternatives BRW Alternatives MYI Alternatives BHMU Alternatives SNN Alternatives WWH Alternatives JTC Alternatives FGT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:RTW) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTW Biotech Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share RTW Biotech Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.